SCHEMBL866336

SCHEMBL866336

Nc1ncnc2c([C@@H]3C[C@@H](COS(N)(=O)=O)[C@@H](O)C3)csc12

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NAE1 Q13564 9/20 0.42
UBA3 Q8TBC4 9/20 0.42
ATG7 O95352 11/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865788 1.00 NAE1 (0.42) NAE1UBA3ATG7
SCHEMBL867174 0.81 NAE1 (0.44) NAE1UBA3
SCHEMBL867353 0.81 NAE1 (0.44) NAE1UBA3
SCHEMBL866507 0.81 NAE1 (0.44) NAE1UBA3
SCHEMBL865836 0.81 NAE1 (0.44) NAE1UBA3
SCHEMBL866063 0.80 NAE1 (0.58) NAE1UBA3
SCHEMBL866387 0.80 NAE1 (0.44) NAE1UBA3
SCHEMBL867498 0.80 NAE1 (0.44) NAE1UBA3
SCHEMBL865882 0.79 NAE1 (0.43) NAE1UBA3
SCHEMBL867053 0.79 NAE1 (0.43) NAE1UBA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES WANG ZHONG (US) 2012-03-29 US claimed
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES WANG ZHONG (US) 2012-03-29 US disclosed
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES WANG ZHONG (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077814-A1 SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES NEDD8, NAE1, UBA3 NAE1 2/4885UBA3 3/4885ATG7 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.